RE:RE:RE:RE:RE:I betThe next news should be within two weeks. The FDA has to grant the Type "A" meeting.
Thry do not have to grant the meeting but given what has happened here I believe they will.
The meeting still has to be held within the 30 day period of request.
The only way they don't sell the company is if the FDA provides a very short path to narrowed approval and possibly guidance to trials for front line treatment.
A partnership only makes sense if the partner pays for trials, if there was interest in that they may as well purchase the company.
I say it goes for 20 to 40 cents, I did think it would be more but I just don't see it.
They still have many high priced executives who will be held and looked after as part of the sale conditions.